View full meeting coverage »

Eyetube Meeting Coverage:

FLORetina 2019

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Anti-PlGF for the Treatment of Diabetic Macular Edema

  Channels: Retina | Posted 6/13/2019

Anat Loewenstein, MD, speaks about the results of the two-stage phase 1/2 trial looking at the safety and efficacy of THR-317, a novel anti-PlGF therapy for the treatment of DME.


2 / 5 Series: FLORetina 2019